Analysis Group Researchers Identify Racial Disparities in Treatment of Metastatic Castration-Sensitive Prostate Cancer

Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale study that revealed racial disparities in treatment, survival, and access to care among patients with metastatic castration-sensitive prostate cancer (mCSPC) since the first novel hormonal therapy was approved in 2018.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Value in Health Regional Issues, the regionally focused journal of ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list.

Expert Panel Publishes Good Practices Recommendations for the Selection, Development, and Modification of Health-Related Performance Outcome Assessments

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of an ISPOR Good Practices Report providing recommendations on performance outcome (PerfO) assessments.

Introducing “Health Years in Total:” A Novel Framework for Valuing Health Outcomes in Cost-Effectiveness Analyses

Lawrenceville, NJ, USA—January 21, 2020—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of an article introducing a new framework for valuing health outcomes in cost-effectiveness analyses. This new…